FDA Scrutinizing Stem Cell Clinics – Financial Advisor Magazine (registration)
Liberty Nation (registration) (blog) |
FDA Scrutinizing Stem Cell Clinics
Financial Advisor Magazine (registration) On Monday, the Food and Drug Administration released a warning letter it sent last week to Florida-based U.S. Stem Cell Inc. for selling unapproved stem–cell treatments and injecting them into patients’ spinal cords. And it raided a San Diego-based … Obama to expand stem cells researchIndependent Online Stem Cell Assay Sales Market 2017 to 2022 Global Research, Analysis and ForecastMedgadget (blog) Stem Cells and “Mishandling” SmallpoxLiberty Nation (registration) (blog) Guardian Liberty Voice –Digital Journal –WhaTech all 18 news articles » |
The Daily Telegram |
FDA clears breakthrough gene therapy for childhood leukemia
The Daily Telegram CAR-T treatment uses gene therapy techniques not to fix disease-causing genes but to turbocharge T cells, immune system soldiers that cancer too often can evade. Researchers filter those cells from a patient’s blood, reprogram them to harbor a … FDA approves first ‘living drug’ for tough childhood leukemiaKTRK-TV FDA announces first US gene therapy approval for cancer treatmentmyfox8.com Breakthrough CAR–T treatment for leukaemia gets FDA nodGears Of Biz |
|
Cell and gene therapies: From clinical to commercial
BioPharma Dive For innovators developing cell and gene therapies, there is a natural flow from clinical trial logistics to commercial logistics. Proactive planning – particularly during the early stages – is vital to establish scalable processes to support patient … |
|
Exploring Immunotherapy for Carcinoid and Pancreatic Neuroendocrine Tumors
Newswise (press release) Newswise — New Brunswick, N.J. – September 5, 2017 – A clinical trial testing the immunotherapy drug pembrolizumab shows the drug to be well tolerated among patients who have carcinoid or pancreatic neuroendocrine tumors. Janice M. Mehnert, MD, … |